Biodistribution of 68/67Ga-radiolabeled sphingolipid nanoemulsions by pet and spect imaging

Abstract

Background and Purpose: Non-invasive imaging methodologies, especially nuclear imaging techniques, have undergone an extraordinary development over the last years. Interest in the development of innovative tracers has prompted the emergence of new nanomaterials with a focus on nuclear imaging and therapeutical applications. Among others, organic nanoparticles are of the highest interest due to their translational potential related to their biocompatibility and biodegradability. Our group has developed a promising new type of biocompatible nanomaterials, sphingomyelin nanoemulsions (SNs). The aim of this study is to explore the potential of SNs for nuclear imaging applications. Methods: Ready-to-label SNs were prepared by a one-step method using lipid derivative chelators and characterized in terms of their physicochemical properties. Stability was assessed under storage and after incubation with human serum. Chelator-functionalized SNs were radiolabeled with67Ga and68Ga, and the radiochemical yield (RCY), radio-chemical purity (RCP) and radiochemical stability (RCS) were determined. Finally, the biodistribution of67/68Ga-SNs was evaluated in vivo and ex vivo. Results: Here, we describe a simple and mild one-step method for fast and efficient radiolabel-ing of SNs with68Ga and67Ga radioisotopes. In vivo experiments showed that67/68Ga-SNs can efficiently and indistinctly be followed up by PET and SPECT. Additionally, we proved that the biodistribution of the67/68Ga-SNs can be conveniently modulated by modifying the surface properties of different hydrophilic polymers, and therefore the formulation can be further adapted to the specific requirements of different biomedical applications. Conclusion: This work supports67/68Ga-SNs as a novel probe for nuclear imaging with tunable biodistribution and with great potential for the future development of nanotheranostics.